These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15731778)

  • 21. Immunohistochemical expression of p53, p21/waf1, rb, p16, cyclin D1, p27, Ki67, cyclin A, cyclin B1, bcl2, bax and bak proteins and apoptotic index in normal thymus.
    Kanavaros P; Stefanaki K; Rontogianni D; Papalazarou D; Sgantzos M; Arvanitis D; Vamvouka C; Gorgoulis V; Siatitsas I; Agnantis NJ; Bai M
    Histol Histopathol; 2001 Oct; 16(4):1005-12. PubMed ID: 11642719
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of cyclin D1, p16 and retinoblastoma protein expressions with prognosis and metastasis of gallbladder carcinoma.
    Ma HB; Hu HT; Di ZL; Wang ZR; Shi JS; Wang XJ; Li Y
    World J Gastroenterol; 2005 Feb; 11(5):744-7. PubMed ID: 15655836
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Results of immunohistochemical staining of cell-cycle regulators: the prediction of recurrence of functioning pituitary adenoma.
    Lee EH; Kim KH; Kwon JH; Kim HD; Kim YZ
    World Neurosurg; 2014; 81(3-4):563-75. PubMed ID: 24067736
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma.
    Milea A; George SH; Matevski D; Jiang H; Madunic M; Berman HK; Gauthier ML; Gallie B; Shaw PA
    Mod Pathol; 2014 Jul; 27(7):991-1001. PubMed ID: 24336157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Alterations of cell cycle regulating proteins: Rb, p21 and p16 in laryngeal cancer].
    Pietruszewska W; Durko M; Kobos J
    Otolaryngol Pol; 2007; 61(6):951-7. PubMed ID: 18546941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy.
    Hwang CF; Cho CL; Huang CC; Wang JS; Shih YL; Su CY; Chang HW
    Ann Oncol; 2002 Aug; 13(8):1246-51. PubMed ID: 12181248
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered expression of G1 regulatory proteins in human soft tissue sarcomas.
    Yoo J; Park SY; Kang SJ; Shim SI; Kim BK
    Arch Pathol Lab Med; 2002 May; 126(5):567-73. PubMed ID: 11958662
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1 in colorectal carcinoma: correlation with other cell cycle regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological features.
    Ioachim E
    Int J Clin Pract; 2008 Nov; 62(11):1736-43. PubMed ID: 19143860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in p53 and pRb pathways and their prognostic significance in oesophageal cancer.
    Mathew R; Arora S; Khanna R; Mathur M; Shukla NK; Ralhan R
    Eur J Cancer; 2002 Apr; 38(6):832-41. PubMed ID: 11937319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations of p53 and Rb Pathways Are Associated with High Proliferation in Bladder Urothelial Carcinomas.
    Goussia AC; Papoudou-Bai A; Charchanti A; Kitsoulis P; Kanavaros P; Kalef-Ezra J; Stefanou D; Agnantis NJ
    Anticancer Res; 2018 Jul; 38(7):3985-3988. PubMed ID: 29970521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors.
    Igarashi T; Jiang SX; Kameya T; Asamura H; Sato Y; Nagai K; Okayasu I
    Mod Pathol; 2004 Oct; 17(10):1259-67. PubMed ID: 15154011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
    Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho AD; Goldschmidt H; Hehlmann R
    Leukemia; 2002 Sep; 16(9):1844-51. PubMed ID: 12200702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.
    Moonen L; Ong F; Gallee M; Verheij M; Horenblas S; Hart AA; Bartelink H
    Int J Radiat Oncol Biol Phys; 2001 Apr; 49(5):1305-10. PubMed ID: 11286838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p18Ink4c and p53 Act as tumor suppressors in cyclin D1-driven primitive neuroectodermal tumor.
    Saab R; Rodriguez-Galindo C; Matmati K; Rehg JE; Baumer SH; Khoury JD; Billups C; Neale G; Helton KJ; Skapek SX
    Cancer Res; 2009 Jan; 69(2):440-8. PubMed ID: 19147556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concurrent disruption of cell cycle associated genes in mantle cell lymphoma: a genotypic and phenotypic study of cyclin D1, p16, p15, p53 and pRb.
    Grønbaek K; Nedergaard T; Andersen MK; thor Straten P; Guldberg P; Møller P; Zeuthen J; Ebbe Hansen N; Hou-Jensen K; Ralfkiaer E
    Leukemia; 1998 Aug; 12(8):1266-71. PubMed ID: 9697882
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of pRB, p16 and cyclin D1 in colonic carcinogenesis.
    Ayhan S; Isisag A; Saruc M; Nese N; Demir MA; Kucukmetin NT
    Hepatogastroenterology; 2010; 57(98):251-6. PubMed ID: 20583423
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of p53, pRb, cyclin D(1) and cdk4 in human oral and pharyngeal squamous cell carcinomas.
    Koontongkaew S; Chareonkitkajorn L; Chanvitan A; Leelakriangsak M; Amornphimoltham P
    Oral Oncol; 2000 Jul; 36(4):334-9. PubMed ID: 10899671
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
    Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
    Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations of the p53, Rb and p27 tumor suppressor pathways in diffuse large B-cell lymphomas.
    Bai M; Tsanou E; Skyrlas A; Sainis I; Agnantis N; Kanavaros P
    Anticancer Res; 2007; 27(4B):2345-52. PubMed ID: 17695524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.